CJ Cheiljedang Corp. proved it has gained popularity in the United States after its latest sales report showed it went over the $73 million mark. This revenue indicated a three-fold increase since it acquired the major US food firm - Schwan's Company - in 2019.
The South Korean food manufacturer said on Monday, Oct. 30, that the collective sales of its frozen rice products which were locally produced and sold in the U.S. have gone beyond the KRW100 billion or $74 million level. The company now expects the numbers to reach more than KRW130 billion or $96 million by the end of this year.
CJ Cheiljedang’s Products in the U.S.
As per The Korea Economic Daily, CJ Cheiljedang’s acquisition of Schwan's Company four years ago greatly helped in its expansion in the country. Since the US-based firm is already an established business, the South Korean food company was able to immediately secure a cold chain distribution system across the nation.
CJ Cheiljedang’s flagship products such as Chicken with Korean BBQ Flavor, Kimchi, Soy Garlic Shrimp, fried rice, and others are now widely distributed there. These food items are being made at Schwan's Vermont manufacturing plant instead of being exported from South Korean plants. These are regularly distributed to major US retail outlets such as Target, Walmart, and Target.
The Popularity of Frozen Rice
CJ CheilJedang believes that the popularity of its frozen rice packages in the U.S. market was due to the adaptation of Korean food culture to suit the palate of the local customers, Korea Joongang Daily reported. The firm added that the most sought-after rice-based processed foods are the kimchi, garlic, and Korean barbecue flavors and these have the biggest sales in the range.
"We added flavors such as Korean BBQ sauce, kimchi, and garlic to the most popular fried rice flavors in the United States, including chicken, vegetables, and shrimp," the company explained.
Photo by: Kawin Harasai/Unsplash


Fonterra Admits Anchor Butter "Grass-Fed" Label Misled Consumers After Greenpeace Lawsuit
CTOC Adds 3,000 Doctors, 500 Hospitals Ahead of Liquidity Push
Chinese Universities with PLA Ties Found Purchasing Restricted U.S. AI Chips Through Super Micro Servers
Apple Turns 50: From Garage Startup to AI Crossroads
BlackRock CEO Larry Fink Earns $37.7 Million in 2025 Amid Record Growth
Annie Altman Amends Sexual Abuse Lawsuit Against OpenAI CEO Sam Altman
Federal Judge Blocks Pentagon's Blacklisting of AI Company Anthropic
Nike Beats Q3 Estimates but China Weakness and Margin Pressure Weigh on Outlook
SoftwareONE Posts 22.5% Revenue Surge in 2025 on Crayon Acquisition
Cybersecurity Stocks Tumble After Anthropic's Claude Mythos AI Leak Sparks Market Fears
Trump Administration Plans 100% Tariffs on Pharmaceutical Imports
RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure
Microsoft Eyes $7B Texas Energy Deal to Power AI Data Centers
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal
Novartis to Acquire Biotech Firm Excellergy in $2 Billion Deal
Luxury Car Sales in the Middle East Take a Hit Amid Iran War
Brazil Meat Exports Weather Iran War Disruptions With Rerouted Shipments 



